Pierrel operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pierrel with three other pharmaceutical manufacturers in Europe: Vistin Pharma ASA of Norway (2017 sales of 176.69 million Norwegian Kroner [US$20.40 million] ), Science In Sport Plc of the United Kingdom (£15.62 million [US$20.07 million] of which 89% was Core), and Replek AD Skopje which is based in Macedonia (955.23 million Denar [US$17.53 million] ).

Sales Analysis. During the year ended December of 2017, sales at Pierrel were 16.84 million Euro (US$18.96 million). This is an increase of 18.0% versus 2016, when the company's sales were 14.27 million Euro.